Page 4 - Pharma Stocks
Pfizer share price up 3% on rolling out this vaccine; key details inside
Pfizer's share price gained today after the company announced the launch of its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
 "Pfizer share price up 3% on rolling out this vaccine; key details inside")
Sai Life Sciences shares surge 11% in 2 days on strong Q1 earnings
The rally in the share price of Sai Life Sciences comes after the company swung back to report a profit of ₹60 crore in Q1FY26
 "Sai Life Sciences shares surge 11% in 2 days on strong Q1 earnings")
Divi's Labs falls 4% after Q1 miss, analysts trim estimates; check details
Divi's Laboratories reported a 14 per cent year-on-year jump in revenue at ₹2,410 crore in Q1FY26, compared to ₹2,118 crore in the year-ago period
 "Divi's Labs falls 4% after Q1 miss, analysts trim estimates; check details")
Alembic Pharma dips 3% post Q1 results; MOFSL retains Neutral, here's why
Alembic Pharma fell around 3.5 per cent to hit an intraday low of ₹913 on the NSE, after the company reported its June 2025 quarter results
 "Alembic Pharma dips 3% post Q1 results; MOFSL retains Neutral, here's why")
Gland Pharma shares jump 6% post Q1 show; should you buy, sell or hold?
The pharma company's profit after tax (PAT) for the quarter ended June 30, 2025, stood at ₹215 crore, up 50 per cent from ₹143 crore reported in the corresponding quarter of the previous fiscal year.
 "Gland Pharma shares jump 6% post Q1 show; should you buy, sell or hold?")
Aurobindo Pharma stock falls 2% after Q1 results; check key numbers here
Aurobindo Pharma's net profit fell 10.2 per cent Y-o-Y to ₹824 crore in Q1FY26, as against ₹918 crore in the same quarter last year
 "Aurobindo Pharma stock falls 2% after Q1 results; check key numbers here")
Tariff worries, Sun Pharma Q1 miss: Why are pharma stocks falling today?
Pharma stocks came under pressure after President Trump announced a 25 per cent tariff rate for Indian exports to the US
Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show
Indoco Remedies announced that it has received a Certificate of EU GMP Compliance from the European Health Authorities for its sterile drug product manufacturing facility at Goa Plant II.
 "Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show")
Dr Reddy's Laboratories Q1 print misses target; brokerages split on outlook
Dr Reddy's Laboratories' posted a revenue of ₹8,545.2 crore, up 11 per cent year-on-year (Y-o-Y) but flat sequentially.
 "Dr Reddy's Laboratories Q1 print misses target; brokerages split on outlook")
Cipla Q1 preview: Net profit may jump up to 4%, revenue by 8% YoY
Cipla is scheduled to announce its April-June quarter earnings for the financial year 2025-26 (Q1FY26) on Friday, July 25, 2025
 "Cipla Q1 preview: Net profit may jump up to 4%, revenue by 8% YoY")
Glenmark, Laurus: 4 pharma stocks gain up to 79% in 5 months; time to exit?
The daily RSI, a key momentum indicator, shows that these 4 pharma stocks namely - Gland Pharma, Glenmark, Biocon and Laurus Labs are trading in the overbought territory; here's what to expect next.
 "Glenmark, Laurus: 4 pharma stocks gain up to 79% in 5 months; time to exit?")
Here's what brokerages expect from Dr Reddy's Labs ahead of Q1 show
Dr Reddy's Labs Q1 preview: The company's net profit is expected to come at ₹1,460 crore, marking around 4.9 per cent Y-o-Y increase, on average, as against ₹1,392.4 crore in Q1 FY25
 "Here's what brokerages expect from Dr Reddy's Labs ahead of Q1 show")
Lupin share price increases on rolling out eye medication; details here
Lupin's share price rose today after the company announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent, in the US market.
 "Lupin share price increases on rolling out eye medication; details here")
Emcure Pharma, Sanofi India shares edge higher; what's behind the move?
Emcure Pharma stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5 as the company announced a distribution and promotion partnership with Sanofi India
 "Emcure Pharma, Sanofi India shares edge higher; what's behind the move?")
Why did Shilpa Medicare share jump 5% in trade today? top details here
Shilpa Medicare share price gained in trade after the company announced a positive regulatory update from the US health regulator, United States Food and Drug Administration (USFDA).
Sun Pharma shares rise 2% on US launch of hair loss drug after settlement
Sun Pharma shares rose nearly 2 per cent on Tuesday after the company launched Leqselvi, a new treatment for severe alopecia areata
 "Sun Pharma shares rise 2% on US launch of hair loss drug after settlement")
Wockhardt shares rise 2% after exiting US generics business
Wockhardt shares rose 2 per cent after it decided to exit the US generic pharmaceutical segment after incurring consistent losses
 "Wockhardt shares rise 2% after exiting US generics business")
Gland Pharma shares rise on GMP nod for Telangana manufacturing unit
Gland Pharma shares rose 2 per cent after it received a GMP certification from the Danish Medicines Agency for its Telangana plant
Glenmark Pharma soars 10%, hits 52-week high on cancer drug licensing deal
At 09:30 AM, Glenmark Pharma shares were trading at ₹2,094.40, up by 10 per cent on the National Stock Exchange.
 "Glenmark Pharma soars 10%, hits 52-week high on cancer drug licensing deal")
Here's why Shilpa Medicare share price is buzzing in trade today; details
Shilpa Medicare shares rose today after the company secured GMP certification from Saudi Arabia's SFDA for its Unit VI facility in Dabaspet, Bengaluru.
